Literature DB >> 3894521

Immunodetection of cell-bound antigens using both mouse and human monoclonal antibodies.

M C Glassy, C D Surh.   

Abstract

A micro enzyme-linked immunoassay (EIA) has been developed for the rapid and sensitive detection of either human or mouse monoclonal antibodies reactive with cell bound antigens. Whole intact cells are immobilized onto 96-well flat bottom microtiter plates by drying in an oven at 37 degrees C overnight prior to the start of the assay. This method of attachment was suitable for all cell types tested, regardless of origin, size and chromosomal content. The dried cells were then rehydrated, incubated with the appropriate test hybridoma supernatant, followed with subsequent analysis by EIA. The plates can be stored at 4 degrees C up to 1 month for future EIA analysis. This assay offers high sensitivity, requires only small amounts of target cells and test hybridoma supernatant, and can be completed within 3 h. This EIA is well suited for the rapid screening of large numbers of hybridoma supernatants and can also be adapted to include cells of any species, providing the appropriate antibody reagents are available.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3894521     DOI: 10.1016/0022-1759(85)90127-9

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  4 in total

1.  Monoclonal antibodies against native ovarian tumor cells: specificity and characterization of the antigen. A preliminary report.

Authors:  L Wasserman; A Neri; B Kaplan; Y Manor; M Galli; B Hardy
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

2.  Growth of human-human hybridomas in serum-free media enhances antibody secretion.

Authors:  M C Glassy; R E Peters; A Mikhalev
Journal:  In Vitro Cell Dev Biol       Date:  1987-11

3.  A monoclonal antibody detecting cell surface epitope on some drug resistant human tumour cell lines.

Authors:  S P Cole; S A Mohamdee; S E Mirski
Journal:  Br J Cancer       Date:  1990-07       Impact factor: 7.640

4.  A human natural antibody to adenocarcinoma that inhibits tumour cell migration.

Authors:  K Koda; N Nakajima; N Saito; J Yasutomi; M E McKnight; M C Glassy
Journal:  Br J Cancer       Date:  1998-11       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.